PRESS RELEASE
News
-
-
PRESS RELEASE
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science provides an update on the application for conditional marketing authorisation of masitinib in the treatment of amyotrophic lateral sclerosis. EMA confirms negative opinion but company remains focused on confirmatory phase 3 program -
PRESS RELEASE
REVENUE FOR THE FIRST NINE MONTHS OF 2024 AND 3RD QUARTER
Showroomprivé (SRP Groupe) reports a slight decline of nearly 1% in Gross Merchandise Value (GMV) up to September 2024, with positive growth trends in international business and premium brands. Strategic transformation initiatives show promising early results -
-
PRESS RELEASE
Participation in the Multilateral System Remains High as Performance Drops, New Index Finds
The Multilateralism Index 2024 by IPI and IEP reveals declining effectiveness despite increased participation in addressing global challenges. Study examines Peace, Security, Human Rights, Climate Action, Public Health, Trade -
PRESS RELEASE
US Med-Equip, Sentec Team Up to Support Clinicians Nationwide With Advanced Respiratory Monitoring for Critical Patients, Including Newborns
US Med-Equip partners with Sentec to offer advanced respiratory monitoring technology, including transcutaneous monitoring and Intrapulmonary Percussive Ventilation for critically ill patients -
-
-
-
PRESS RELEASE
THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients
